Authors: | Mohan, M.; Becnel, M. R.; Shah, U. A.; Dong, H.; Gundarlapalli, S.; Peterson, T.; Orozco, J. S.; Horowitz, S.; Chhabra, S.; Dhakal, B.; Thanendrarajan, S.; Radhakrishnan, S. V.; Al Hadidi, S.; Tan, C.; Mailankody, S.; Hultcrantz, M.; Korde, N.; Hassoun, H.; Lesokhin, A. M.; Thomas, S. K.; Patel, K. K.; Manasanch, E. E.; Weber, D. M.; Szabo, A.; Kaufman, G. P.; Lee, H. C.; Zangari, M.; van Rhee, F.; Usmani, S. Z.; D'Souza, A.; Orlowski, R. Z.; Schinke, C. |
Title: | Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi-institutional experience |
Keywords: | adult; controlled study; treatment outcome; aged; treatment failure; human cell; major clinical study; overall survival; genetics; lenalidomide; clinical trial; cancer recurrence; drug efficacy; treatment duration; letter; bortezomib; multiple cycle treatment; multiple myeloma; gene expression profiling; cohort analysis; cytogenetics; dexamethasone; autologous stem cell transplantation; retrospective study; monoclonal antibody; antibodies, monoclonal; multicenter study; drug response; drug dose sequence; carfilzomib; proof of concept; pomalidomide; humans; human; daratumumab; isatuximab; immunological antineoplastic agent; antineoplastic agents, immunological; adp ribosyl cyclase/cyclic adp ribose hydrolase 1; adp-ribosyl cyclase 1 |
Journal Title: | American Journal of Hematology |
Volume: | 97 |
Issue: | 7 |
ISSN: | 0361-8609 |
Publisher: | John Wiley & Sons, Inc. |
Date Published: | 2022-07-01 |
Start Page: | E276 |
End Page: | E280 |
Language: | English |
DOI: | 10.1002/ajh.26580 |
PUBMED: | 35472167 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | Letter -- Export Date: 1 July 2022 -- Source: Scopus |